H. Lôo

1.8k total citations
72 papers, 1.3k citations indexed

About

H. Lôo is a scholar working on Psychiatry and Mental health, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, H. Lôo has authored 72 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Psychiatry and Mental health, 15 papers in Pharmacology and 13 papers in Cellular and Molecular Neuroscience. Recurrent topics in H. Lôo's work include Schizophrenia research and treatment (24 papers), Treatment of Major Depression (13 papers) and Bipolar Disorder and Treatment (12 papers). H. Lôo is often cited by papers focused on Schizophrenia research and treatment (24 papers), Treatment of Major Depression (13 papers) and Bipolar Disorder and Treatment (12 papers). H. Lôo collaborates with scholars based in France, Canada and Belgium. H. Lôo's co-authors include M F Poirier, E. Zarifian, W. Rein, O. Fleurot, Michel Theron, Salomón Z. Langer, Anne‐Marie Galzin, D. Sechter, Marie‐Odile Krebs and M.-C. Bourdel and has published in prestigious journals such as American Journal of Psychiatry, Neurology and Biological Psychiatry.

In The Last Decade

H. Lôo

68 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H. Lôo France	21	661	408	330	209	191	72	1.3k
Ion Anghelescu Germany	21	557 0.8×	354 0.9×	360 1.1×	233 1.1×	235 1.2×	54	1.6k
Jeffery A. Lieberman United States	11	566 0.9×	360 0.9×	203 0.6×	175 0.8×	283 1.5×	14	1.1k
Don Goff United States	10	596 0.9×	471 1.2×	195 0.6×	300 1.4×	338 1.8×	13	1.3k
Jeffrey M. Goldstein United States	24	782 1.2×	555 1.4×	224 0.7×	274 1.3×	161 0.8×	67	1.6k
David Pickar United States	17	599 0.9×	553 1.4×	328 1.0×	216 1.0×	295 1.5×	19	1.7k
Keith G. Kramlinger United States	13	649 1.0×	313 0.8×	298 0.9×	212 1.0×	186 1.0×	17	1.5k
Enrico Lattuada Italy	25	837 1.3×	571 1.4×	325 1.0×	282 1.3×	133 0.7×	44	1.6k
J. Fritze Germany	17	428 0.6×	368 0.9×	188 0.6×	225 1.1×	174 0.9×	56	1.4k
Jun Ishigooka Japan	24	757 1.1×	196 0.5×	291 0.9×	241 1.2×	223 1.2×	123	1.6k
Richard L. Borison United States	27	1.1k 1.6×	547 1.3×	385 1.2×	310 1.5×	182 1.0×	66	1.9k

Countries citing papers authored by H. Lôo

Since Specialization

Citations

This map shows the geographic impact of H. Lôo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Lôo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Lôo more than expected).

Fields of papers citing papers by H. Lôo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Lôo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Lôo. The network helps show where H. Lôo may publish in the future.

Co-authorship network of co-authors of H. Lôo

This figure shows the co-authorship network connecting the top 25 collaborators of H. Lôo. A scholar is included among the top collaborators of H. Lôo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Lôo. H. Lôo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sentissi, Othman, et al.. (2013). Intérêt de l’électroconvulsivothérapie de maintenance dans les troubles de l’humeur. L Encéphale. 39(5). 367–373. 1 indexed citations

Lôo, H., Jan Govaere, Koen Chiers, et al.. (2010). Hydrops uteri bij een Belgisch witblauwe vaars gepaard gaand met een mandibulair vasculair hamartoma bij het kalf. Vlaams Diergeneeskundig Tijdschrift. 79(2). 1 indexed citations

Gallarda, Thierry & H. Lôo. (2009). Dépression et personnes âgées. L Encéphale. 35(3). 269–280. 19 indexed citations

Mouchet-Mages, Sabine, Raphaël Gourévitch, & H. Lôo. (2008). Folie à deux : actualités d’un concept ancien, à propos de deux cas. L Encéphale. 34(1). 31–37. 17 indexed citations

Bossaert, Philippe, et al.. (2008). De pathogenese en kliniek van ketonemie en leververvetting bij hoogproductieve melkkoeien. Vlaams Diergeneeskundig Tijdschrift. 77(5). 2 indexed citations

Bossaert, Philippe, et al.. (2008). De behandeling en preventie van ketonemie en leververvetting bij hoogproductieve melkkoeien. Vlaams Diergeneeskundig Tijdschrift. 77(6). 1 indexed citations

Bourdel, M.-C., H. Lôo, Jean‐Pierre Olié, et al.. (2005). Traitement du contexte visuospatial chez des patients schizophrènes non traités – influence de la désorganisation. L Encéphale. 31(3). 323–329. 7 indexed citations

Gourion, D., Raphaël Gourévitch, Jean-Sébastien Provost, et al.. (2004). L’hypothèse neurodéveloppementale dans la schizophrénie. L Encéphale. 30(2). 109–118. 36 indexed citations

Lôo, H., et al.. (2002). [Pilot study comparing in blind the therapeutic effect of two doses of agomelatine, melatonin- agonist and selective 5HT2c receptors antagonist, in the treatment of major depressive disorders].. PubMed. 28(2). 165–62. 47 indexed citations

10.

Gourion, D., Céline Goldberger, M.-C. Bourdel, et al.. (2001). [French validation of a Minor Morphologic Anomalies Scale in schizophrenic patients and their parents].. PubMed. 27(2). 143–7. 12 indexed citations

11.

Lôo, H., Pilar A. Sáiz, M. Ansseau, et al.. (1999). Efficacy and safety of tianeptine in the treatment of depressive disorders in comparison with fluoxetine. Journal of Affective Disorders. 56(2-3). 109–118. 34 indexed citations

12.

Krebs, Marie‐Odile, François Sautel, Pierre Sokoloff, et al.. (1998). Dopamine D3 receptor gene variants and substance abuse in schizophrenia. Molecular Psychiatry. 3(4). 337–341. 59 indexed citations

13.

Lôo, H., et al.. (1997). Amisulpride versus placebo in the medium-term treatment of the negative symptoms of schizophrenia. The British Journal of Psychiatry. 170(1). 18–22. 140 indexed citations

14.

Lôo, H., et al.. (1997). Tianeptine and alcohol dependence. European Neuropsychopharmacology. 7. S347–S351. 21 indexed citations

15.

Fleck, Marcelo P., et al.. (1995). Factorial structure of the 17‐item Hamilton Depression Rating Scale. Acta Psychiatrica Scandinavica. 92(3). 168–172. 61 indexed citations

16.

Grasela, Thaddeus H., et al.. (1993). Predictive performance of population pharmacokinetic parameters of tianeptine as applied to plasma concentrations from a post-marketing study. European Journal of Clinical Pharmacology. 45(2). 123–128. 5 indexed citations

17.

Guéguen, B., Sandrine Guillou, Christian Derouesné, et al.. (1991). Analyse topographique des potentiels évoqués endogènes chez des sujets âgés déprimés et chez des sujets atteints de démence de type Alzheimer. Neurophysiologie Clinique. 21(5-6). 449–458. 1 indexed citations

18.

Lôo, H., et al.. (1990). Psychopathological and sociodemographic characteristics of 1231 depressed patients with and without co-existing alcoholism. 5(4). 249–255. 3 indexed citations

19.

Martinot, J. L., P Péron-Magnan, Bernard Mazoyer, et al.. (1989). Striatal D2 dopaminergic receptor status ascertained in vivo by positron emission tomography and 76Br-bromospiperone in untreated schizophrenics. Psychiatry Research. 29(3). 357–358. 10 indexed citations

20.

Etévenon, P., P Péron-Magnan, Sandrine Guillou, et al.. (1988). Cafeine et cartographie EEG: Effets d'une tache visuospatiale chez des volontaires sains. Strategie d'analyse des donnees electropharmacologiques. Neurophysiologie Clinique. 18(4). 355–367. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact